Researchers have found an antibody, imatinib, that eliminates chronic myeloid leukemia stem cells in mice and isolated human cancer cells and could keep one form of the disease from persisting after treatment.
To access this subscriber-only content please log in or renew your subscription.
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe
Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.
Login Subscribe